Last week, the FDA gave 510(K) clearance to the first needle-free wearable, Biolinq Shine, that can track glucose, sleep and activity all in a single device. This builds on Biolinq’s De Novo classification from the FDA last fall, which established a new regulatory category for wearable, needle-free metabolic biosensors.
Read More.